Table 1 Clinical characteristics and demographics of patients on ECMO
Clinical characteristics | N | Demographics | All | Survivors | Non-survivors | p-value |
|---|---|---|---|---|---|---|
Diagnosis |  | Age (years) | 14 (1–18) | 9 (4–16) | 16 (1–18) | 0.286 |
 ALL | 5 | Weight (kg) | 47 (7–74) | 26 (12–50) | 56 (7–74) | 0.286 |
 AML | 3 | Pre ECMO |  |  |  |  |
 JMML | 1 | pH | 7.2 (7.0–7.6) | 7.3 (7.0–7.6) | 7.2 (7.0–7.4) | 0.413 |
Reason for ARF |  | Lactate (mg/dL) | 17 (7–68) | 17 (7–24) | 17 (8–68) | 0.556 |
 Fungal infection | 3 | pO2/FiO2 | 47 (32–67) | 66 (32–67) | 44 (34–50) | 0.286 |
 Pulmonary infectiona | 4 | VIS score | 45 (5–160) | 11 (5–45) | 85 (22–160) | 0.032 |
 TRALI | 1 | Platelet count (×  103/μL) | 27 (14–214) | 145 (26–214) | 27 (14–53) | 0.111 |
 Leukemic infiltration | 1 | Ventilation days | 3 (0.4–14) | 4.5 (1–13) | 2 (0.4–12) | 0.556 |
Causes of death on ECMO | Â | During ECMO | Â | Â | Â | Â |
 Intracranial hemorrhage | 1 | Platelet count (×  103/μL) | 35 (19–106) | 98 (22–106) | 30 (19–48) | 0.041 |
 Multiorgan failure | 2 | Platelets transfusions / day | 2.2 (0.2–3.8) | 0.5 (0.2–2.2) | 3.3 (1.7–4.7) | 0.111 |
 Leukemic infiltration | 1 | VV Cannulation | 7 | 5 | 2 |  |
Outcome on ECMO | Â | VA Cannulation | 2 | 0 | 2 | Â |
 Survived on ECMO | 5 | Major bleeding | 4 | 0 | 4 |  |
 Discharged from hospital | 4 | Need for CRRT | 3 | 0 | 3 |  |
 Survived long-term | 4 | ECMO Duration (days) | 14 (2–24) | 15 (9–24) | 5 (2–17) | 0.032 |